Medpace Holdings ROA 2014-2025 | MEDP
Current and historical return on assets (ROA) values for Medpace Holdings (MEDP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Medpace Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-06-30 | $0.42B | $1.57B | 21.84% |
| 2025-03-31 | $0.42B | $1.90B | 20.79% |
| 2024-12-31 | $0.40B | $2.10B | 20.45% |
| 2024-09-30 | $0.37B | $2.08B | 19.58% |
| 2024-06-30 | $0.34B | $1.92B | 19.83% |
| 2024-03-31 | $0.31B | $1.80B | 19.73% |
| 2023-12-31 | $0.28B | $1.66B | 19.03% |
| 2023-09-30 | $0.27B | $1.49B | 19.43% |
| 2023-06-30 | $0.27B | $1.41B | 19.62% |
| 2023-03-31 | $0.26B | $1.40B | 19.07% |
| 2022-12-31 | $0.25B | $1.35B | 18.36% |
| 2022-09-30 | $0.23B | $1.33B | 16.01% |
| 2022-06-30 | $0.21B | $1.32B | 14.18% |
| 2022-03-31 | $0.20B | $1.34B | 13.22% |
| 2021-12-31 | $0.18B | $1.66B | 11.82% |
| 2021-09-30 | $0.18B | $1.58B | 12.36% |
| 2021-06-30 | $0.17B | $1.47B | 12.41% |
| 2021-03-31 | $0.16B | $1.45B | 11.79% |
| 2020-12-31 | $0.14B | $1.39B | 11.41% |
| 2020-09-30 | $0.12B | $1.30B | 10.34% |
| 2020-06-30 | $0.11B | $1.22B | 9.36% |
| 2020-03-31 | $0.11B | $1.14B | 10.07% |
| 2019-12-31 | $0.10B | $1.14B | 9.44% |
| 2019-09-30 | $0.09B | $1.07B | 9.06% |
| 2019-06-30 | $0.09B | $1.02B | 8.83% |
| 2019-03-31 | $0.08B | $1.01B | 7.91% |
| 2018-12-31 | $0.07B | $0.97B | 7.57% |
| 2018-09-30 | $0.06B | $0.95B | 6.45% |
| 2018-06-30 | $0.05B | $0.97B | 5.52% |
| 2018-03-31 | $0.05B | $0.97B | 4.80% |
| 2017-12-31 | $0.04B | $0.95B | 4.07% |
| 2017-09-30 | $0.03B | $0.95B | 2.90% |
| 2017-06-30 | $0.02B | $0.96B | 2.37% |
| 2017-03-31 | $0.02B | $0.97B | 2.46% |
| 2016-12-31 | $0.01B | $0.98B | 2.66% |
| 2016-06-30 | $0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.288B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.699B | 26.28 |
| CVS Health (CVS) | United States | $78.241B | 9.72 |
| Elevance Health (ELV) | United States | $66.788B | 8.98 |
| Cencora (COR) | United States | $56.876B | 19.79 |
| DiDi Global (DIDIY) | China | $27.957B | 29.70 |
| Labcorp Holdings (LH) | United States | $20.968B | 17.01 |
| Natera (NTRA) | United States | $18.819B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.728B | 0.00 |
| ICON (ICLR) | Ireland | $13.558B | 13.05 |
| CochLear (CHEOY) | Australia | $13.493B | 0.00 |
| Solventum (SOLV) | United States | $12.872B | 13.63 |
| Revvity (RVTY) | United States | $11.722B | 20.17 |
| Viatris (VTRS) | United States | $10.997B | 3.78 |
| Avantor (AVTR) | United States | $9.267B | 13.47 |
| Sonic Healthcare (SKHHY) | Australia | $9.129B | 0.00 |
| HealthEquity (HQY) | United States | $8.380B | 36.71 |
| Charles River Laboratories (CRL) | United States | $8.249B | 16.17 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.640B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.038B | 29.67 |
| BrightSpring Health Services (BTSG) | United States | $3.745B | 34.35 |
| Sotera Health (SHC) | United States | $3.364B | 19.11 |
| Surgery Partners (SGRY) | United States | $2.848B | 37.03 |
| Organon (OGN) | United States | $2.626B | 2.79 |
| Concentras Parent (CON) | United States | $2.584B | 14.93 |
| Alignment Healthcare (ALHC) | United States | $2.453B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.367B | 91.15 |
| Progyny (PGNY) | United States | $2.011B | 44.26 |
| PACS (PACS) | United States | $1.821B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.800B | 36.00 |
| Premier (PINC) | United States | $1.761B | 13.37 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.505B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.249B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.126B | 8.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.999B | 342.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.786B | 7.35 |
| CareDx (CDNA) | United States | $0.731B | 11.41 |
| Embecta (EMBC) | United States | $0.680B | 4.58 |
| So-Young (SY) | China | $0.557B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.540B | 0.00 |
| Nutex Health (NUTX) | United States | $0.516B | 7.81 |
| SBC Medicals (SBC) | United States | $0.510B | 0.00 |
| Omada Health (OMDA) | $0.496B | 0.00 | |
| LifeMD (LFMD) | United States | $0.493B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| Enhabit (EHAB) | United States | $0.350B | 28.83 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.255B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.155B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.117B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |